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Simultaneous bilateral quadriceps tendon rupture is a rare injury. We report the case of bilateral 
quadriceps tendon rupture sustained with minimal force while refereeing a football game. The injury 
was suspected to be associated with statin use as the patient had no other identifiable risk factors. 
The diagnosis was confirmed using bedside ultrasound. [West J Emerg Med. 2010; 11(4):306-309.]
INTRODUCTION
Simultaneous bilateral quadriceps tendon rupture is a 
rare injury. As of 2009, only 70 cases have been reported 
in the English literature. Although rare, most cases have 
been associated with chronic metabolic disturbances or 
inflammatory diseases in patients over the age of 50.1 
Iatrogenic causes of bilateral quadriceps rupture, including 
steroid and flouroquinolone use, have also been identified 
in the literature.2-6 Although HMG-CoA reductase inhibitor 
(statin)-associated musculoskeletal complaints have been 
reported, few have involved tendon rupture.7-11  We present 
a case of simultaneous bilateral quadriceps tendon rupture 
in which the only identifiable risk factor was statin use. The 
diagnosis was confirmed using bedside ultrasound.  
CASE REPORT
A 56-year-old African-American male presented to the 
emergency department (ED) complaining of what he described 
as “torn muscles to the right and left knee.” The patient stated 
that he was refereeing a football game and, while running, 
suddenly felt his right knee buckle. As he was falling to the 
ground, he also felt a pop in the left knee. The patient 
described severe pain to both knees and was unable to 
ambulate.
At the time of examination in the ED, the patient denied 
pain at rest, numbness or tingling. The patient did report 
swelling around the knees, particularly at the superior aspect. 
The patient’s past medical history was remarkable only 
for hyperlipidemia, for which he had been taking atorvastatin 
(lipitor), 20 mg once daily, for about three years. He stated he 
had stopped the medication three weeks prior to the injury and 
denied previously being on any other cholesterol-lowering 
agent. He denied other past medical history, specifically renal 
problems, hypertension, metabolic problems, joint diseases, 
previous orthopedic injuries or other chronic illnesses. He also 
denied other medication use, including steroids, herbal 
supplements or fluoroquinolones in the preceding six months. 
Furthermore, he denied previous musculoskeletal problems 
prior to or during treatment with atorvastatin. His past 
surgical, family and social histories were all unremarkable. 
On physical exam, the patient was an athletic-appearing 
male who looked younger than his stated age, sitting up on the 
stretcher in no acute distress. Vital signs revealed a blood 
pressure of 149/75, but were otherwise within normal limits. 
All portions of the exam were unremarkable except for the 
musculoskeletal exam. Observation revealed swelling to both 
knees, left greater than right, without ecchymosis, skin 
lacerations or open fractures. He had visible defects superior to 
the patella bilaterally. There was tenderness to palpation of 
both distal quadriceps tendons. The thigh and leg 
compartments were soft. There was full passive range of 
motion of both knees with pain, but active range of motion was 
severely limited. The patient was unable to straight-leg-raise 
due to complete absence of knee extension bilaterally. There 
was full active range of motion of both ankles and 5/5 strength 
when tested. He was neurovascularly intact.
Anterior-posterior and lateral radiographs of the right and 
left knees showed a thickening of the quadriceps tendon with 
pre-patellar bursitis on the left and normal findings on the 
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Bedside ultrasound was performed for confirmation of 
suspected bilateral quadriceps tendon rupture. A linear probe 
was used to scan the patient bilaterally revealing complete 
disruption of both quadriceps tendons with anechoic fluid 
collections noted superiorly, representing hematomas. Both 
sides appeared similar on ultrasound, verifying the diagnosis 
of bilateral spontaneous quadriceps tendon ruptures (Figure 1 
and Figure 2).
Following an orthopedic surgery consult in the ED, the 
patient was discharged with bilateral knee immobilizers, pain 
medication and outpatient surgery appointment. Six days later, 
intraoperative examination confirmed bilateral complete 
quadriceps tendon ruptures at the osseotendinous junction, and 
open repair was performed.
The patient was admitted for two days for pain control.  
While in the hospital the patient was found to be hypertensive 
and was started on metoprolol, 50 mg by mouth twice 
daily. According to the patient, the hypertension was likely 
secondary to pain because his primary doctor stopped the 
antihypertensive medication after which he had no problems 
with blood pressure control.
Once pain control was achieved with oral medications, the 
patient was discharged to a rehab facility for further care, 
where he remained for four days before discharged home. 
Instructions upon hospital discharge were to weight-bear as 
tolerated on both legs as long as the knee immobilizers were 
in place. Range-of-motion was gradually increased over the 
next four weeks.
Four months postoperatively the patient continued to be 
followed in the orthopedic clinic and had achieved 95 degrees 
of knee flexion bilaterally. However, the patient continued to 
suffer knee stiffness and was unable to ambulate four months 
following operative repair.  
Investigation into possible causes of the patient’s 
bilateral quadriceps tendon ruptures identified only oral statin 
administration as a suspected risk factor. Laboratory analysis 
revealed a normal comprehensive metabolic panel with a 
creatinine of 1.1 and normal serum calcium.
DICUSSION
We report a rare case of bilateral quadriceps tendon 
rupture associated with statin use. We performed a review of 
the English language literature using the National Library of 
Medicine and National Institutes of Health database and 
identified only 70 cases. The first case of bilateral quadriceps 
tendon rupture was reported by Steiner and Palmer in 
1949.12 The majority of bilateral quadriceps tendon rupture 
have occurred in men over 50, and in those with risk factors 
such as obesity, diabetes mellitus, chronic renal failure and 
hyperparathyroidism.1,13-18 Of the reported cases in our review, 
none were clearly associated with statin use.  
Although there are no reported cases of bilateral 
quadriceps tendon rupture associated with statin use, these 
cholesterol-lowering agents have been reported to be 
associated with the development of musculoskeletal 
complaints, including tendonitis and unilateral tendon 
rupture.7-10  For example, in a study of 96 patients with 
tendonitis or tendon rupture believed to be associated with 
statin use, 14 ruptures involved the quadriceps tendon but 
none were bilateral.10 Although unproven, several case reports 
Figure	1.	Sagittal view of right quadriceps tendon rupture Figure	2.	Transverse view of right quadriceps tendon rupture
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suggest an association between tendon injury and statin 
therapy.11,19  In addition, several tendinopathies have been 
reported involving a statin combined with ezetimibe, another 
cholesterol-lowering agent.20-21 A recent case-control study 
examining the association between statins and tendon rupture 
found no significant association compared with control 
groups.22 Thus the association of statin use and tendon rupture 
remains ill-defined.
There are several hypotheses that attempt to explain the 
association of statin use with tendon injury. The exact cause 
remains unresolved, but a combination of suppressive effects 
on matrix metalloproteinase activity and prostaglandin E2 
activity is thought to play a major role.20,23-24 These enzymes 
are active in the remodeling process in tendons, but when 
disrupted could potentially lead to tendon weakening or even 
rupture.
Multiple large clinical trials have demonstrated the 
efficacy of statins as cholesterol-lowering agents and in their 
ability to decrease the risk of myocardial infarctions, angina 
and revascularization procedures in patients with coronary 
artery disease.25-29 Knowledge of the cases of tendon injury 
that do occur and the classes of patients that may be more at 
risk for developing certain adverse reactions could allow for 
prevention in some individuals.
As the prevalence of obesity and type II diabetes mellitus 
increases in the United States, many Americans are being 
treated for hyperlipidemia with statins. It is possible that 
statin-associated tendinopathy and tendon rupture will become 
more frequent, and physicians should be aware of the possible 
relationship between statin therapy and tendon rupture when 
treating their patients with cholesterol-lowering medications. 
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